Singapore’s Temasek Holdings has invested USD47.8M in California-based Amyris Biotechnologies. Amyris’ proprietary technology transforms plant-based feedstocks, such as sugarcane into biofuels.
Amyris has previously raised USD244M.
Temasek joins this investor line-up: Kleiner Perkins Caufield & Byers, Khosla Ventures, TPG Biotechnology, Votorantim Novos Negocios, Advanced Equities Inc., DAG Ventures, Grupo Cornélio Brennand, Naxos U.K., The Westly Group, and Stratus Group.
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
